Patents-Review.com
🔗 Permalink
Inventor profile of:

Catherine Taylor

City:

Waterloo

Country:

Canada

Published Applications:

21

Last publication date:

2014-12-18

Top Assignees for applications by Catherine Taylor

The entities that hold a legal rights for patent applications filed by inventor Taylor Catherine:

Recent patent applications by Taylor Catherine

Catherine Taylor from Waterloo, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2014-12-18
US20140371299A1
Chemistry; metallurgy

Use of Apoptosis-Specific elF-5A siRNA to Down Regulate Expression of Proinflammatory Cytokines to Treat Sepsis

 #2 | 2014-07-31
US20140212969A1
Chemistry; metallurgy

Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis

 #3 | 2014-06-19
US20140171374A1
Chemistry; metallurgy

USE OF A TRUNCATED EIF-5A1 POLYNUCLEOTIDE TO INDUCE APOPTOSIS IN CANCER CELLS

 #4 | 2013-03-14
US20130066058A1
Chemistry; metallurgy

Use of Antisense Oligonucleotides or siRNA to Suppress Expression of eIF-5A1

 #5 | 2012-05-24
US20120129910A1
Chemistry; metallurgy

Inhibition of apoptosis-specific eIF-5A(eIF-5A1″) with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics

 #6 | 2012-03-15
US20120064625A1
Chemistry; metallurgy

Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis

 #7 | 2011-11-24
US20110288156A1
Human necessities

Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis

 #8 | 2011-06-28
US10200148
-

Method for inducing apoptosis using apoptosis-specific EIF5-A

 #9 | 2011-04-28
US20110098460A1
Chemistry; metallurgy

siRNA useful to supress expression of EIF-5A1

 #10 | 2010-07-01
US20100168047A9
Chemistry; metallurgy

Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics

 #11 | 2010-03-25
US20100076062A1
Chemistry; metallurgy

Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells

 #12 | 2008-06-03
US10383614
-

Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye

 #13 | 2007-10-11
US20070238691A1
Chemistry; metallurgy

Inhibition of HIV replication and expression of p24 with eIF-5A

 #14 | 2007-05-15
US10277969
-

Nucleic acids, polypeptides, and methods for modulating apoptosis

 #15 | 2007-03-15
US20070059831A1
Chemistry; metallurgy

Expression vector encoding apoptosis-specific eIF-5A

 #16 | 2007-01-23
US10141647
-

Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis

 #17 | 2006-12-21
US20060287265A1
Chemistry; metallurgy

Apoptosis-specific eIF-5A and polynucleotides encoding same

 #18 | 2006-08-10
US20060178330A1
Chemistry; metallurgy

Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1

 #19 | 2006-07-13
US20060154887A1
Chemistry; metallurgy

Use of apoptosis-specific eIF-5A siRNAs and antisense polynucleotides to inhibit/suppress an inflammatory response

 #20 | 2006-05-04
US20060094677A1
Chemistry; metallurgy

Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics

 #21 | 2005-03-15
US9909796
-

DNA encoding apoptosis-induced eucaryotic initiation factor-5A and deoxyhypusine synthase and a method for controlling apoptosis in animals and humans
InventorID:

141527 ⎘